ZJ: cardiac clinical 🫀 Flashcards
L: Arrhythmia and Anticoagulation
Whats an arrythmia? and 2 possible reasons for it
change in normal rate/rhythm of heart.
- altered impulse gen e.g. changes in automaticity of pacemaker cells in SAN/ APs from elsewhehre
- altered impulse conduction e.g. complete/ partial block of conduction pathways in myocardium
3 types of arrhythmias?
- bradycardia: HR < 60bpm
- tachycardia: HR > 100bpm
- AF
whats sinus bradycardia?
and what might bradyc. also be caused by?
slowed HR but rhythm unchanged.
heart block
whats the differenc ebetween supra-ventricular tachycardia and ventricular tachycardia?
SVT: arise above level of ventricles wither within atria
VT: arise within ventricles themselves
how may sinus tachycardia occur?
HR increased but rhythm unchanged
affect of rapid atrial rate and disturbance of conduction pathways in atrial flutter?
increased risk of localised thrombus formation and secondary embolic events (i.e. thrombotic stroke)
most common type of arrythmias and who is it more prevalent in/risk factors?
atrial FIBRILLATION
- older people
- hypertensive
- HF
- coronary artery disease
- valvular artery disease
- obesity
- DM
- CKD
- caffeine
- alcohol
- cardiac surgery
- stress
- pulmonary embolism
complications of AF?
stroke
congestive HF
AF symptoms
- breathless
- light headed
- fatigue
- palpitations- racing, pounding, thumping in chest
- chest pain
how is AF diagnosed in prim care?
WatchBP: oscillometric BP monitor (microlife).
records BP and detects pulse irregularity that may be caused by symptomatic/asymptomatic AF.
whats AF often associated with?
other arrhythmias: atrial flutter/ supraventricular tachycardia
what may occur during treatment of AF with anti-arrhythmic drugs?
atrial flutter
6 classes of antiarrhythmic meds:
Na+ channel blockers (and affect phase 0)
- IA
- IB
- IC
beta blocker
- II
K+ channel blocker
-III
Ca+ channel blcoker
- IV
why monitor for bradycardia when using II anti-arrhythmic drugs.
have beta blocker mechanism of action.
block symp activity; reduce rate! and conduction
AF diagnosis?
- ECG
- ECHO
- TFTs
- CXR.
also maybe thyoid function
3 types of AF?
paroxysmal: spontaneous within 7 days
persistent: > 7 days
permanent: over a year. needs management
how is AF managed?
arrhythmia control (by rhythm/rate control)
thromboprohylaxis: to prevent strokes
treat underlying caus
NICE: rate control is offered as first line strategy in AF patients EXCEPT?
- if their AF has reversible cause
- have HF primarily caused by AF
- new onset AF
- rhythm control strategy more suited (clinical judgement)
rate control guidelines: what is offered (2) as part of strategy? NICE
standard beta blcoker or
rate limiting calcium channel blocker as initial monotherapy
consider digoxin monotherapy for those with non-paroxysmal AF only if theyre sedentary.
if doesnt work, consider combination therapy with:
- beta blcoker
- diltiazem
- digoxin
rate control guidelines: what must not be offered for long term rate control?
amiodarone
what must be considered (2) for patients with AF?
pharmacological and/or electrical rhythm control
what is offered as therapy for patients having cardioversion for AF, thats persisted longer than 48h?
- offer electrical (instead of pharmacological) cardioversion.
- consider: amiodarone starting 4wks before and contrinuing up to 12 months after: electrical cardioversion. maintaining sinus rhyhtm.
- discuss benefits/risks of amiodarone.
long term treatment options for rhythm control
- standard beta blocker first line unless contraindicated: then assess comorbidities:
- dronedarone for maintenance of sinus rhythm after successful cardioversion in those with paroxysmal/persistent AF/
what drugs to avoid in tretment of rhythm control in patients with known ischaemic/structural heart disease?
class 1c antiarrhythmic drugs e.g. flecainide/propafenone
what strategies should be considered in people with infrequent paroxysms and few symptoms/ where symptoms induced by known factors (alcohol/caffeine)?
‘no drug treatment’/’pill in the pocket’
what is amiodarone and what type of effects does it have?
whats its dominant effect?
- iodine containing. struc similar to thyroxine.
- complex effects.
- Clas I, II, III, IV actions.
- dominant effect = prolongation of AP and refractory period.
amiodarone pahrmacokinetics
- incompletely absorbed after oral admin
- unusual: prolonged half life of several wks and extensively distributed in adipose tissue
- full clinical effects after months of treatment start
common side effects of amiodarone
- interstitial pulmonary fibrosis
- hyper/hypothyroidism
- liver tox
- photosensitivity: affect skin. wear big hats, sunscreen
- blue skin discolour- iodine accumulation in skin
amiodarone counselling points
- possible phototox: shield skin from light during treatment and months after.
- use wide spectrum sunscreen
- blurred vision- counsel on driving and skilled tasks
- symptoms of bradycardia and heart block if taken with sofosbuvir- containing regiments.
- compliance
- dont drink grapefruit juice: higher chance of SE
- Do not take if allergic to iodine.
- Discuss with your pharmacist or doctor if you are intolerant to lactose
non drug treatment options (5)
- ablation (pulmonary vein)
- ablate and pace (AV node ablation)
- atrial defibrillators
- maze procedure
- removal of left atrial appendage
antithrombotic therapy:
- risk and benefits of anticoags
- place of NOACs in AF management
due to rhythm abnormalities with AF, what is there a risk of to patient? how is this risk assessed?
risk of blood clotting.
using CHA2DS2-VASc scale
with CHA2DS2-VASc scale, which patients dont require antithrombotic therapy?
patients with AF who are clearly low risk. (age<65 and lone AF).
= males with score 0
= females with score 1 (point for F sex)
CHA2DS2-VASc scale: score 0-9 with 9 as highest annual stroke rate.
what are each points assigned for?
The acronym CHA2DS2-VASc stands for
Congestive heart failure, Hypertension, Age ≥75 (doubled), Diabetes, Stroke (doubled), Vascular disease, Age 65 to 74 and Sex category (female)
what scale/score is used to assess bleeding risk in patients started on anticoagulation
HAS-BLED:
Hypertension: Uncontrolled, >160 mmHg systolic Absorbance renal/ liver function: 1/2 Stroke history Bleeding Labile INR Elderly >65 Drugs/alcohol use: 1/2
score= 3: increased 1 year bleed risk
whats the other clinical prediction calcluator for decisions on non-VKA oral anticoag (NOAC) and a vitK antagonist (VKA)?
the SAMe-TT2R2 score
role of anticoagulant?
preventing stroke and arrhythmias consequences
5 examples of anticoag?
apixaban dabigatran etexilate rivaroxiban edoxaban vit K antag e.g. warfarin
warfarin is a well established VKA that requires…
regular blood tests and counselling as many interactions
what is warfarin indicated for and what 2 things done prior to starting therapy?
PE, DVT, AF, mechanical heart valves etc…
- rule out contrainds e.g. active bleeding (main SE)
- baseline international normalised ratio (INR) taken
effect of anticoagulant therapy e.g. warfarin on INR
normal INR = 1.
warfarin adjusts this to 2-4.
i.e. anti-coagulated blood taken 4x as long to clot
target INR for:
a) AF, DVT, PE
b) mechanic heart valve?
a) 2-3
b) 2.3-3.5
how to initiate warfarin therapy for: patients requiring rapid anticoag?
- 5-10mg on 1st day (lower induction dose for elderly)- given with a heparin usually LMWH.
- continue for min. 5 days and until INR=2 for 2 consec days.
- subsequent doses depend on prothrombin time, reported as INR.
how to initiate warfarin therapy for: patients NOT requiring rapid anticoag?
-lower LD over 3-4wks
daily maintence: 3-9mg. taken at same time each day. (-6pm)
in which situations is INR regularly/not reg monitored?
if patients on oral anticoags- monitor INR
NOACS/DOACS- dont need to monitor INR
how do the following NOACS/DOACS work?
a) dabigatran etexilate
b) rivaroxiban and apixaban
c) edoxaban
a) direct thrombin inhibitor
b) inhibit activated factor Xa
c) reversive and direct inhib of activated factor X (factor Xa)
whats recommended as an alternative to warfarin and what used for?
NOACS= alternative.
prevention of stroke, systemic embolism in patients with AF.
how do NOACS compare with warfarin in reduction of relative risk of stroke and systemic embolism in AF patients?
NOACS are as effective as warfarin :)
what patients is anticoagulation offered to?
people with CHA2DS2-VASc score of 2 or more.
taking bleeding risk into account
do not offer aspirin therapy solely for….
stroke prevention to people with AF
() when may idarucizumab (PRAXBIND) be used?
when rapid reversal of anticoag effects of DABIGATRAN is needed for emergency surgery/urgent procedures / in life threatening/uncontrolled bleeding
but studies of efficacy and safety are ongoing.
noacs side effects
bleeding,
minor (e.g., slight bruising/ occasional bleeding from the gums when bruising teeth) –> serious (e.g., vomiting blood, blood in stools/urine/ bleeding inside head).
2 types of heparin and the differences?
UFH- unfractioned: conventional heparin
- large mucopolysacc mols
- immediate anticoag properties
LMWH- low MW hep
- smaller polysacc chains
- longer and more predicatble half life than UFH
what does UFH do and how does it compare with LMWH?
UFH
prevents production of fibrin from fibrinogen
also has effects on inhibition of production of activated clotting factors.
LMWH
anticoag effect by inactivating factor Xa
which heparin more suitable for renal impairment?
UFH as short half life than LMWH- which also exreted renally.
how is UFH administered?
IV/ SC
adverse effects of the heparins?
UFH: major= haemorrhage
LMWH: potential= heparin induced thrombocytopenia. smaller risk
when is APTT coag monitoring required and when is it not?
req for high dose heparin
no need for LMWH
whats Fondaparinux and when used?
synthetic pentasacc - inhibits activated factor X.
use: prophylaxis of VTE and treatment of DVT, PE.
used in acute management of MI.
what has a greater risk of intracranial haemorrhage: warfarin/DOACS?
warfarin
time to get to peak effect (Tmax) for DOACS?
immediate anticoag effect: 1-4hrs
is effect of missed doses greater for warfarin or DOACs and why?
greater loss of anticoag from missed doses for DOACS and they have a shorter half life
3 points to do before prescribing doacs/ warfarin?
- view patient holistically- comorbidities, indications for use of DOACS for appr treatment
- review compliancee
- review all meds, check inetractions.
clincially: whats checked before prescribing warfarin/doacs?
- renal function and consider cautions and dose adjustments
e. g. apixaban risk of bleeding if eGFR <15ml/min/1.73m2… - monitor renal func annually esp in elderly w age relaed decline in kidney func
- review hepatic impairment, avoid in severe impairment
- account for patient weight if needed.
L: cardiac clinical pharmacy
how can drugs affect heart function? 2
direct: force of contraction or rate/rhythm
indirect: vasculature or BV/composition- diuretics
whats CO? and eqn?
CO= HR x SV
vol of blood ejected for each vent contraction
2 things SV is determined by?
preload/ LV EDP
afterload: pressure in wall of LV during ejection
inotropy: contractility
What determines contractility?
the myocardial striated muscle, involving Ca2+
What do inotropic drugs affect?
the force of the heart contractions
What do positive inotropic drugs do and how?
Increase force of heart’s contraction by increasing calcium, therefore increase heart rate
What do negative inotropic drugs do? give example drug
decrease the force of the heart’s contraction and therefore decrease heart rate
Verapamil
What are 3 inotropic drug classes?
- Cardiac glycosides
- Sympathomimetics
- Phosphodiesterase inhibitors
How does digoxin work?
image p46 s1 w9
- inhibits cell memb Na+/K+ATPase -> reversal of usual Na/Ca exchange
- normally, ⬆ intracellular Ca -> enhanced strength of contraction (+ inotropism)
- also affects elec physiology of heart, blocking (AV) conduction and ⬇ HR by enhancing vagal nerve activity
⬆Ca, contraction, HR
What is the principal indication of digoxin?
permanent/persistent Atrial Fibrillation (AF) with a fast ventricular rate - but not preferred first-line
What does NICE guidance suggest digoxin should be used as first-line in?
patients with AF who also have co-existing HF
Digoxin is reserved for patients where the heart failure is due to… and has worsened despite the use of…
- due to left ventricular dysfunction
- despite the use of angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and diuretic therapy (No impact on mortality).
Is the therapeutic index of digoxin low or high? What action should be taken?
low, so patients should be reviewed for clinical signs
What are the signs and symptoms of digoxin toxicity?
- Bradycardia
- Arrhythmia
- Nausea, vomiting
- Confusion
- Visual disturbances, blurred or yellow vision
Digoxin toxicity is more pronounced with what types of disturbances? What action should be taken consequently?
with metabolic or electrolyte disturbance (potassium levels?) - electrolyte monitoring is important